Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00887_DB00930> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00887_DB00930 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00887_DB00930 label "DDI between Bumetanide and Colesevelam - Bile acid sequestrants such as colesevelam may decrease the absorption of loop diuretics such as bumetanide. Monitor for decreased serum concentrations/therapeutic effects of loop diuretics if coadministered with bile acid sequestrants. Separating the administration of doses by 2 or more hours may reduce (but not eliminate) the risk of interaction. The manufacturer of colesevelam recommends that drugs should be administered at least 1 hour before or 4 hours after colesevelam. [drugbank_resource:DB00887_DB00930]" assertion.
- drugbank_resource:DB00887_DB00930 identifier "drugbank_resource:DB00887_DB00930" assertion.
- drugbank_resource:DB00887_DB00930 title "DDI between Bumetanide and Colesevelam - Bile acid sequestrants such as colesevelam may decrease the absorption of loop diuretics such as bumetanide. Monitor for decreased serum concentrations/therapeutic effects of loop diuretics if coadministered with bile acid sequestrants. Separating the administration of doses by 2 or more hours may reduce (but not eliminate) the risk of interaction. The manufacturer of colesevelam recommends that drugs should be administered at least 1 hour before or 4 hours after colesevelam." assertion.